Delivery Order 36F79720D0148-36C24525N0995
- The U.S. Department of Veterans Affairs Veterans Integrated Service Network 20 (VISN 20) awarded a delivery order to Harmony Biosciences LLC for the supply of bulk WAKIX 17.8 mg tablets, a pharmaceutical product used to treat excessive daytime sleepiness and cataplexy in narcolepsy patients. This firm fixed-price delivery order, valued at $619,879.33, was awarded on December 1, 2025, with a completion date of June 30, 2026, and will be performed in Pittsburgh, Pennsylvania. The award was...
- Harmony Biosciences LLC was awarded a firm fixed price delivery order for $10,170 against the General Services Administration's Pharmaceuticals and Drugs Federal Supply Schedule to provide WAKIX tablets. The tablets will treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients under the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. Performance will occur in Plymouth Meeting, Pennsylvania by June 2024. No set-aside...
- This is a firm-fixed-price delivery order for WAKIX 17.8 MG tablets, awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company specializing in rare neurological diseases and sleep disorders. The order, valued at $10,418.40, was placed against Harmony Biosciences' existing Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA. This delivery order is part of a larger $5 million Blanket...
- Harmony Biosciences LLC has been awarded a firm fixed price delivery order valued at $10,170 to supply WAKIX 17.8 MG tablets. The contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 against the General Services Administration Federal Supply Schedule for Pharmaceuticals and Drugs. Performance will take place in Pittsburgh, Pennsylvania by January 31, 2024. No set-aside designation was applied to this order to fulfill...
- This federal contract award is for the delivery of WAKIX 17.8 MG tablets to the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5. The $10,418.14 firm fixed price delivery order was awarded to Harmony Biosciences LLC, a for-profit pharmaceutical company that specializes in developing and manufacturing medications for rare neurological diseases and sleep disorders. The contract is issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule and supports...
- This federal contract award is a delivery order valued at $656,342.82 issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company that specializes in developing and manufacturing medications for rare neurological diseases and sleep disorders. The award is for the bulk order of WAKIX (pitolisant) tablets, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. Harmony...
- This is a federal contract award from the Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a pharmaceutical company that specializes in medications for rare neurological diseases and sleep disorders. The contract is a Delivery Order under the VA's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs, with a ceiling value of $10,418.14. The contract is for the supply of WAKIX 17.8 mg, a medication used to treat excessive daytime sleepiness and cataplexy in adult...
- This is a federal contract award to Harmony Biosciences LLC, a pharmaceutical company specializing in medications for rare neurological diseases and sleep disorders. The contract is a delivery order with a firm fixed price for the supply of WAKIX 17.8 mg tablets to the Department of Veterans Affairs (VA) through the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract has a ceiling value of $10,418.14 and a completion date of August 26, 2025. Harmony Biosciences LLC also...
- This is a firm-fixed-price delivery order from the U.S. Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC for the prescription drug WAKIX (pitolisant). The order is valued at $5,085.00 and is being placed against Harmony Biosciences' General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). Harmony Biosciences, a for-profit pharmaceutical company specializing in rare neurological diseases...
- This federal contract award to Harmony Biosciences LLC, a pharmaceutical company, is a delivery order against the General Services Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Valued at $10,170.00, this firm-fixed-price order is for the medication WAKIX 17.8 MG, which is used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The order is placed by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration to...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79720D0148Federal Supply Schedule
- 36F79720D0148-36C24525N0995Delivery Order
Harmony Biosciences LLC received a $10,418.14 firm fixed-price delivery order from Veterans Integrated Service Network 5 (VISN 5), a civilian component of the Department of Veterans Affairs, for WAKIX 17.8 mg tablets. The award was issued on September 15, 2025, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with an ultimate completion date of September 18, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed in Pittsburgh, Pennsylvania. WAKIX is a specialized pharmaceutical product used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients, supporting the VA's mission to provide comprehensive healthcare to veterans. This delivery order falls under a larger $25 million Blanket Purchase Agreement that Harmony Biosciences LLC holds with the VA National Acquisition Center, covering the period from June 2025 through June 2026. The company also maintains a $259,000 indefinite-delivery indefinite-quantity contract with VA Veterans Health Administration. These contract vehicles enable the VA to efficiently procure WAKIX across multiple Veterans Integrated Service Networks and medical centers nationwide, streamlining the acquisition process for this critical narcolepsy medication within the veterans healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 9/15/25 |